The CEO of $PRVCF discusses the deal they've struck with private firm Asterion Cannabis Inc to develop medical CBD products. In the companies’ sights via the joint venture are tablets, transdermal patches and other jointly evaluated products aimed at treating chronic pain, inflammation, epilepsy, anxiety disorders and others. Learn more at: https://www.preveceutical.com


https://youtu.be/OujHc7Orn_I